NEX-T Trademark

Trademark Overview


On Tuesday, December 8, 2020, a trademark application was filed for NEX-T with the United States Patent and Trademark Office. The USPTO has given the NEX-T trademark a serial number of 90366677. The federal status of this trademark filing is ABANDONED - FAILURE TO RESPOND OR LATE RESPONSE as of Monday, April 11, 2022. This trademark is owned by BRISTOL-MYERS SQUIBB COMPANY. The NEX-T trademark is filed in the Pharmaceutical Products and Medical & Beauty Services & Agricultural Services categories with the following description:

Pharmaceutical preparations for the treatment of cancer and auto-immune diseases; pharmaceutical preparations for the treatment of lymphoma; pharmaceutical preparations for inhibiting cytokine production; pharmaceutical preparations that modulate the immune system; pharmaceutical preparations, namely, preparations for use in the treatment of tumors; pharmaceutical and biological preparations for immunotherapy, including T Cell therapy; cells for medical or clinical use; diagnostic kits consisting primarily of cells for medical or clinical use

Collection and preservation of human biological tissue, blood and cells; medical diagnostic services; medical treatment services; provision of information and data for diagnosis and medical treatment
nex-t

General Information


Serial Number90366677
Word MarkNEX-T
Filing DateTuesday, December 8, 2020
Status602 - ABANDONED - FAILURE TO RESPOND OR LATE RESPONSE
Status DateMonday, April 11, 2022
Registration Number0000000
Registration DateNOT AVAILABLE
Mark Drawing4000 - Illustration: Drawing with word(s) / letter(s) / number(s) in Block form
Published for Opposition DateNOT AVAILABLE

Trademark Statements


Goods and ServicesPharmaceutical preparations for the treatment of cancer and auto-immune diseases; pharmaceutical preparations for the treatment of lymphoma; pharmaceutical preparations for inhibiting cytokine production; pharmaceutical preparations that modulate the immune system; pharmaceutical preparations, namely, preparations for use in the treatment of tumors; pharmaceutical and biological preparations for immunotherapy, including T Cell therapy; cells for medical or clinical use; diagnostic kits consisting primarily of cells for medical or clinical use
Pseudo MarkNEXT
Goods and ServicesCollection and preservation of human biological tissue, blood and cells; medical diagnostic services; medical treatment services; provision of information and data for diagnosis and medical treatment

Classification Information


International Class005 - Pharmaceutical and veterinary preparations; sanitary preparations for medical purposes; dietetic substances adapted for medical use, food for babies; plasters, materials for dressings; material for stopping teeth, dental wax; disinfectants; preparations for destroying vermin; fungicides, herbicides.
US Class Codes005, 006, 018, 044, 046, 051, 052
Class Status Code6 - Active
Class Status DateSaturday, February 13, 2021
Primary Code005
First Use Anywhere DateNOT AVAILABLE
First Use In Commerce DateNOT AVAILABLE

International Class044 - Medical services; veterinary services; hygienic and beauty care for human beings or animals; agriculture, horticulture and forestry services.
US Class Codes100, 101
Class Status Code6 - Active
Class Status DateSaturday, February 13, 2021
Primary Code044
First Use Anywhere DateNOT AVAILABLE
First Use In Commerce DateNOT AVAILABLE

Trademark Owner History


Party NameBRISTOL-MYERS SQUIBB COMPANY
Party Type10 - Original Applicant
Legal Entity Type03 - Corporation
AddressNew York, NY 10016

Trademark Events


Event DateEvent Description
Tuesday, April 12, 2022ABANDONMENT NOTICE E-MAILED - FAILURE TO RESPOND
Monday, April 11, 2022ABANDONMENT NOTICE MAILED - FAILURE TO RESPOND
Monday, April 11, 2022ABANDONMENT - FAILURE TO RESPOND OR LATE RESPONSE
Wednesday, July 14, 2021APPLICANT/CORRESPONDENCE CHANGES (NON-RESPONSIVE) ENTERED
Wednesday, July 14, 2021ASSIGNED TO LIE
Wednesday, June 9, 2021TEAS VOLUNTARY AMENDMENT RECEIVED
Wednesday, May 19, 2021NOTIFICATION OF NON-FINAL ACTION E-MAILED
Wednesday, May 19, 2021NON-FINAL ACTION E-MAILED
Wednesday, May 19, 2021NON-FINAL ACTION WRITTEN
Tuesday, May 11, 2021ASSIGNED TO EXAMINER
Saturday, February 13, 2021NEW APPLICATION OFFICE SUPPLIED DATA ENTERED IN TRAM
Friday, December 11, 2020NEW APPLICATION ENTERED IN TRAM